Insights

Sustainable focus Small biotechnology firm with a novel immune refocusing technology targeting human and veterinary diseases presents opportunities to partner on co-developed vaccines or licensed biologics, especially in areas with limited existing vaccines.

Global expansion potential BMI aims to address resistant and emergent pathogens across human and veterinary medicine, indicating potential sales opportunities in both medical markets and animal health channels as they advance from R&D to commercialization.

Innovative tech edge Immune Refocusing Technology offers a differentiator for vaccines and monoclonal antibodies, suggesting opportunities for collaborations with biotech manufacturers, contract development and manufacturing organizations (CDMOs), and research partners seeking novel antigenicity modulation.

Financial signaling Revenue range of one to ten million signals a small but growing company likely open to licensing deals, partnerships, and grant-driven programs to scale capabilities and expand product portfolios without bearing heavy capital expenditure.

Strategic partnerships Given emphasis on both human and veterinary biologics, BMI may be a fit for cross-sector partnerships with larger vaccine players or veterinary pharma firms seeking innovative platforms to broaden their pipeline and address serotype- or strain-limited protection gaps.

Similar companies to Biological Mimetics, Inc.

Biological Mimetics, Inc. Tech Stack

Biological Mimetics, Inc. uses 8 technology products and services including jQuery CDN, RSS, Mailchimp, and more. Explore Biological Mimetics, Inc.'s tech stack below.

  • jQuery CDN
    Content Delivery Network
  • RSS
    Content Management System
  • Priority Hints
    Performance
  • HSTS
    Security
  • Bootstrap
    UI Frameworks
  • Apache
    Web Servers
  • Apache HTTP Server
    Web Servers

Biological Mimetics, Inc.'s Email Address Formats

Biological Mimetics, Inc. uses at least 4 email formats:
Biological Mimetics, Inc. Email FormatsExamplePercentage
Last@bmi-md.comDoe@bmi-md.com
60%
First.Last@bmi-md.comJohn.Doe@bmi-md.com
20%
FLast@bmi-md.comJDoe@bmi-md.com
13%
F.Last@bmi-md.comJ.Doe@bmi-md.com
7%

Frequently Asked Questions

What is Biological Mimetics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Biological Mimetics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Biological Mimetics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Biological Mimetics, Inc.'s official website is bmi-vaccine.com and has social profiles on LinkedIn.

How much revenue does Biological Mimetics, Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, Biological Mimetics, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Biological Mimetics, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Biological Mimetics, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Biological Mimetics, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, Biological Mimetics, Inc. has approximately 8 employees across 2 continents, including North America and South America. Key team members include General Manager: R. S. and Ingeniera: M. J. R. R. Explore Biological Mimetics, Inc.'s employee directory with LeadIQ.

What industry does Biological Mimetics, Inc. belong to?

Minus sign iconPlus sign icon
Biological Mimetics, Inc. operates in the Biotechnology Research industry.

What technology does Biological Mimetics, Inc. use?

Minus sign iconPlus sign icon
Biological Mimetics, Inc.'s tech stack includes jQuery CDN, RSS, Mailchimp, Priority Hints, HSTS, Bootstrap, Apache and Apache HTTP Server.

What is Biological Mimetics, Inc.'s email format?

Minus sign iconPlus sign icon
Biological Mimetics, Inc.'s email format typically follows the pattern of Last@bmi-md.com. Find more Biological Mimetics, Inc. email formats with LeadIQ.

When was Biological Mimetics, Inc. founded?

Minus sign iconPlus sign icon
Biological Mimetics, Inc. was founded in 1996.
Biological Mimetics, Inc. logo

Biological Mimetics, Inc.

Biotechnology ResearchMaryland, United States2-10 Employees

Biological Mimetics, Inc. is a small biotechnology research company based in Frederick, Maryland. The firm focuses on developing and commercializing biologics for human and veterinary medicine, aiming to address resistant and emerging diseases across viruses, bacteria, parasites, and cancer. The company has developed a technology platform, Immune Refocusing Technology (IRT), built on an understanding of deceptive imprinting, a mechanism of antigenic variation used by certain pathogens and cancer cells to evade the immune system. 

Its researchers describe IRT as a means to alter the natural antigenicity and immunogenicity of targeted protein antigens, with applications to vaccines that currently have limited protection and to vaccines for pathogens without effective options. The approach is also positioned to support the generation of monoclonal antibodies and, in some contexts, to modulate therapeutic proteins to improve their half-life and safety profiles. BMI operates with a small team in the biotechnology sector, applying its platform to human and veterinary biological products.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1996
Employees
2-10

Section iconFunding & Financials

  • $1M - $10M

    Biological Mimetics, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.